mounjaro glp-1 Stroke: GLP-1s Like Ozempic, May Reduce Cardiovascular Risks Mounjaro (Tirzepatide): Raising the Bar
Description
These drugs treat chronic conditions requiring ongoing management, though individual circumstances and consultation with your healthcare provider should guide discontinuation decisions
Diabetes 10 (5), 291303
Posted on Lancet September 12, 2022
A recent study found no correlation between short- and long-acting of GLP-1 RA, dose, and duration of use with a percentage of patients in all categories experiencing residual gastric contents
Melissa Sleight, RDN Medical Reviewer Judy Mouchawar, MD, MSPH Medical Reviewer Judy Mouchawar, MD, MSPH, is a medical director in clinical affairs
